Treatments
927 articles
Slowing the Growth of One Type of Advanced Neuroendocrine Tumor
Dr. Kelsey Klute explains the advantages of the radiopharmaceutical lutetium Lu 177 dotatate treatment for certain neuroendocrine tumors.
New FDA Approval Brings More Treatment Options in Metastatic Disease
The FDA has approved the use of liposomal irinotecan in the chemotherapy combination NALIRIFOX for metastatic pancreatic cancer.
I Wanted Immunotherapy!
When Daniel Miller was diagnosed with pancreatic cancer he knew he didn’t want chemotherapy—he wanted immunotherapy!
Understanding How Super-Enhancers Rev Up Pancreatic Cancer Growth
Researcher Ronald Evans, Ph.D., and his team at the Salk Institute are focusing on how super-enhancers stimulate pancreatic cancer growth.
Is Pancreatic Cancer Different in Black Patients?
Pancreatic cancer occurs at a higher rate in Black patients. Dr. Howard Crawford leads a study looking at the cancer biology for differences.
Focus on Joy
Long-term survivor Marisa Harris shares her thoughts on surviving, thriving, and making the most of your time while in treatment.
I’m a Person, Not a Diagnosis
Burt Rosen discusses his life with PNET, making sure he is a person, and more than his diagnosis.
Let’s Win! Pancreatic Cancer Survivors Series—Year Four
Our inspiring Survivors video series is entering Year Four. Meet more long-term survivors as well as researchers working for new treatments.
New Immunotherapy Strategy Aimed at High-Risk Population
Dr. Neeha Zaidi is the lead investigator of an immunotherapy trial using a vaccine for people at high risk for pancreatic cancer.
Two New Immunotherapy Trials Aim to Make Therapy More Effective
Two clinical trials in the Lustgarten Foundation’s Clinical Accelerator are testing different combinations of immunotherapy.
Large Phase III Global Trial Targets Cancer Metabolism
Dr. Philip Philip focuses on disrupting cancer cell metabolism with devimistat, now in a phase III global clinical trial.
AACR Annual Meeting 2021 Highlights
Let’s Win and the Lustgarten Foundation bring you the pancreatic cancer research highlights of the 2021 AACR Annual Meeting,
RNA Precision Trial for Pancreatic Cancer Opens At Columbia
Dr. Andrea Califano leads a precision oncology clinical trial of the OncoTreat platform, which looks at proteins to determine treatment.
Cachexia Research Gaining Momentum
Why do pancreatic cancer patients lose weight even if they are eating well? Dr. Teresa Zimmers explains the syndrome called cachexia.
An Interview with Dr. Tyler Jacks
Dr. Tyler Jacks is one of the leading pancreatic cancer researchers. Read what he has to say about KRAS, organoids, and running a lab in a pandemic.